Showing results (1-10 of 31) with videos related to
Sort By:
Pageof 4
Reproductive Toxicology (Elmsford, N.Y.)|July 10, 2003
Suppression of decidual cell response induced by dibutyltin dichloride in pseudopregnant rats: as a cause of early embryonic lossAkira Harazono, Makoto EmaJournal of Pharmaceutical and Biomedical Analysis|May 15, 2012
Rapid evaluation for heterogeneities in monoclonal antibodies by liquid chromatography/mass spectrometry with a column-switching systemRyosuke Kuribayashi, Noritaka Hashii, Akira Harazono, et al.Analytical Biochemistry|September 29, 2011
Analysis of oligomeric stability of insulin analogs using hydrogen/deuterium exchange mass spectrometryShiori Nakazawa, Noritaka Hashii, Akira Harazono, et al.Journal of Proteomics|February 18, 2014
Selective glycopeptide profiling by acetone enrichment and LC/MSDaisuke Takakura, Akira Harazono, Noritaka Hashii, et al.Toxicology Letters|May 17, 2003
Protective effects of progesterone on implantation failure induced by dibutyltin dichloride in ratsMakoto Ema, Akira Harazono, Akihiko Hirose, et al.Glycobiology|December 24, 2004
Site-specific glycosylation analysis of human apolipoprotein B100 using LC/ESI MS/MSAkira Harazono, Nana Kawasaki, Toru Kawanishi, et al.Journal of Pharmaceutical Sciences|October 7, 2021
Quantitative Evaluation of Insoluble Particulate Matters in Therapeutic Protein Injections Using Light Obscuration and Flow Imaging MethodsHiroko Shibata, Akira Harazono, Masato Kiyoshi, et al.Rapid Communications in Mass Spectrometry : RCM|March 14, 2014
Characterization of N-glycan heterogeneities of erythropoietin products by liquid chromatography/mass spectrometry and multivariate analysisNoritaka Hashii, Akira Harazono, Ryosuke Kuribayashi, et al.Journal of Pharmaceutical and Biomedical Analysis|May 28, 2013
Mass spectrometric glycoform profiling of the innovator and biosimilar erythropoietin and darbepoetin by LC/ESI-MSAkira Harazono, Noritaka Hashii, Ryosuke Kuribayashi, et al.Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|May 7, 2025
Characterization of Biosimilar Monoclonal Antibodies and Their Reference Products Approved in Japan to Reveal the Quality Characteristics in Post-approval PhaseHiroko Shibata, Akira Harazono, Masato Kiyoshi, et al.Pageof 4